The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis

References

• Hashimoto Y. Retinobenzoic acids and nuclear retinoic acid receptors. Cell Struct Funct. 1991;16:113–23.
   PubMed Web of Science ®Google Scholar
• Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996;10:940–54.
   PubMed Web of Science ®Google Scholar
• Sporn MB, Roberts AB. Cervical dysplasia regression induced by all-trans-retinoic acid. J Natl Cancer Inst. 1994;86:476–7.
   PubMedGoogle Scholar
• Beehler BC, Brinckerhoff CE, Ostrowski J. Selective retinoic acid receptor ligands for rheumatoid arthritis. Curr Opin Investig Drugs. 2004;5:1153–7.
   Google Scholar
• Kang BY, Chung SW, Kim SH, Kang SN, Choe YK, Kim TS. Retinoid-mediated inhibition of interleukin-12 production in mouse macrophages suppresses Thl cytokine profile in CD4± T cells. Br J Pharmacol. 2000;130:581–6.
   PubMed Web of Science ®Google Scholar
• Kirchmeyer M, Koufany M, Sebillaud S, Netter P, Jouzeau JY, Bianchi A. All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation. Arthritis Res Ther. 2008;10:R141.
   PubMed Web of Science ®Google Scholar
• Pino-Lagos K, Benson MJ, Noelle RJ. Retinoic acid in the immune system. Ann N Y Acad Sci. 2008;1143:170–87.
   PubMed Web of Science ®Google Scholar
• Hoag KA, Nashold FE, Goverman J, Hayes CE. Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-present-ing cells. J Nutr. 2002;132:3736–9.
   PubMed Web of Science ®Google Scholar
• Iwata M, Eshima Y, Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th 1 development and enhance Th2 development via retinoic acid receptors. Int Immunol. 2003;15: 1017–25.
   Google Scholar
• Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-a favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol. 2007;37:2396–9.
   PubMed Web of Science ®Google Scholar
• Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach EM, et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood. 2008;111:1013–20.
   PubMed Web of Science ®Google Scholar
• Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317:256–60.
   PubMed Web of Science ®Google Scholar
• Nanki T, Lipsky PE. Cytokine, activation marker, and chemokine receptor expression by individual CD4± memory T cells in rheumatoid arthritis synovium. Arthritis Res. 2000;2:415–23.
   PubMedGoogle Scholar
• Morita Y, Yamamura M, Kawashima M, Harada S, Tsuji K, Shibuya K, et al. Flow cytometric single-cell analysis of cytokine production by CD4± T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum. 1998;41:1669–76.
   PubMed Web of Science ®Google Scholar
• Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi JI, Kaibara N, et al. Thl but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:1299–304.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963–70.
   PubMed Web of Science ®Google Scholar
• Raza K, Falciani F, Curnow SJ, Ross RI, Lee CY, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005;7:R784–95.
   PubMed Web of Science ®Google Scholar
• Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, et al. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remis-sion induced by all-trans retinoic acid. Blood. 1997;90:967–73.
   PubMed Web of Science ®Google Scholar
• Miwako I, Kagechika H. Tamibarotene. Drugs Today (Bart). 2007;43:563–8.
   PubMed Web of Science ®Google Scholar
• Ohnishi K. PML-RARa inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int J Clin Oncol. 2007;12:313–7.
   PubMed Web of Science ®Google Scholar
• Kuwabara K, Shudo K, Hon i Y. Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels. FEBS Lett. 1996;378:153–6.
   Google Scholar
• Takeda N, Manabe I, Shindo T, Iwata H, Iimuro S, Kagechika H, et al. Synthetic retinoid Am80 reduces scavenger receptor expression and atherosclerosis in mice by inhibiting IL-6. Arte-rioscler Thromb Vase Biol. 2006;26:1177–83.
   PubMedGoogle Scholar
• Kagechika H. Novel synthetic retinoids and separation of the pleiotropic retinoidal activities. Curr Med Chem. 2002;9:591–608.
   PubMedGoogle Scholar
• Ohyanagi N, Ishido M, Suzuki F, Kaneko K, Kubota T, Miyasaka N, et al. Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody produc-tion in vivo. Arthritis Rheum. 2009;60:3118–27.
   PubMedGoogle Scholar
• Klemann C, Raveney BJ, Klemann AK, Ozawa T, von Horsten S, Shudo K, et al. Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am J Pathol. 2009;174(6):2234–45.
   PubMed Web of Science ®Google Scholar
• Nagai H, Matsuura S, Bouda K, Takaoka Y, Wang T, Niwa S, et al. Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice. Pharmacology. 1999;58:101–12.
   PubMedGoogle Scholar
• Wakamatsu K, Nanki T, Miyasaka N, Umezawa K, Kubota T. Effect of a small molecule inhibitor of nuclear factor-KB nuclear translocation in a murine model of arthritis and cultured human synovial cells. Arthritis Res Ther. 2005;7:R1348–59.
   Google Scholar
• Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bers-selaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004;50: 650–9.
   Google Scholar
• Bush KA, Farmer KM, Walker JS, Kirkham BW. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum. 2002;46:802–5.
   PubMed Web of Science ®Google Scholar
• Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173–7.
   PubMed Web of Science ®Google Scholar
• Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4± effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–32.
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133–41.
   PubMed Web of Science ®Google Scholar
• Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol. 1997;158:5501–6.
   Google Scholar
• Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997;158:5507–13.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Joms JM, et al. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res 'Ther. 2009;11:R158.
   Google Scholar
• Mohty M, Morbelli S, Isnardon D, Sainty D, Arnoulet C, Gaugler B, et al. All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells. Br J Haematol. 2003;122:829–36.
   PubMedGoogle Scholar
• Wei J, Duramad O, Pemg OA, Reiner SL, Liu YJ, Qin FX. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3± regulatory T cells. Proc Natl Acad Sci USA. 2007;104:18169–74.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hong J, Sun W, Xu G, Li N, Chen X, et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4±CD25— T cells to CD4± Tregs. J Clin Invest. 2006;116:2434–41.
   PubMed Web of Science ®Google Scholar
• Nozaki Y, Yamagata T, Sugiyama M, Ikoma S, Kinoshita K, Funauchi M. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin Immunol. 2006;119:272–9.
   PubMed Web of Science ®Google Scholar
• Tokuyama H, Tokuyama Y. The regulatory effects of all-trans-retinoic acid on isotype switching: retinoic acid induces IgA switch rearrangement in cooperation with IL-5 and inhibits IgG1 switching. Cell Immunol. 1999;192:41–7.
   PubMedGoogle Scholar
• Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, et al. Blockage of interleukin-6 receptor amelio-rates joint disease in murine collagen-induced arthritis. Arthritis Rheum. 1998;41:2117–21.
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, et al. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 respon-ses. Arthritis Rheum. 2008;58:3710–9.
   PubMedGoogle Scholar
• Nagpal S, Cai J, Zheng T, Patel S, Masood R, Lin GY, et al. Retinoid antagonism of NF-1L6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Mol Cell Biol. 1997;17:4159–68.
   PubMedGoogle Scholar